These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16439592)

  • 1. Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis.
    Fukami M; Hasegawa T; Horikawa R; Ohashi T; Nishimura G; Homma K; Ogata T
    Pediatr Res; 2006 Feb; 59(2):276-80. PubMed ID: 16439592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/ tetrahydroxycortisone ratio and 11β-hydroxyandrosterone.
    Koyama Y; Homma K; Fukami M; Miwa M; Ikeda K; Ogata T; Hasegawa T; Murata M
    Clin Chem; 2012 Apr; 58(4):741-7. PubMed ID: 22273564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone.
    Homma K; Hasegawa T; Nagai T; Adachi M; Horikawa R; Fujiwara I; Tajima T; Takeda R; Fukami M; Ogata T
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2643-9. PubMed ID: 16608896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Krone N; Reisch N; Idkowiak J; Dhir V; Ivison HE; Hughes BA; Rose IT; O'Neil DM; Vijzelaar R; Smith MJ; MacDonald F; Cole TR; Adolphs N; Barton JS; Blair EM; Braddock SR; Collins F; Cragun DL; Dattani MT; Day R; Dougan S; Feist M; Gottschalk ME; Gregory JW; Haim M; Harrison R; Olney AH; Hauffa BP; Hindmarsh PC; Hopkin RJ; Jira PE; Kempers M; Kerstens MN; Khalifa MM; Köhler B; Maiter D; Nielsen S; O'Riordan SM; Roth CL; Shane KP; Silink M; Stikkelbroeck NM; Sweeney E; Szarras-Czapnik M; Waterson JR; Williamson L; Hartmann MF; Taylor NF; Wudy SA; Malunowicz EM; Shackleton CH; Arlt W
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E257-67. PubMed ID: 22162478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.
    Bai Y; Li J; Wang X
    J Ovarian Res; 2017 Mar; 10(1):16. PubMed ID: 28288674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects.
    Fukami M; Ogata T
    Pediatr Int; 2014 Dec; 56(6):805-808. PubMed ID: 25294558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
    Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A male twin infant with skull deformity and elevated neonatal 17-hydroxyprogesterone: a prismatic case of P450 oxidoreductase deficiency.
    Wudy SA; Hartmann MF; Draper N; Stewart PM; Arlt W
    Endocr Res; 2004 Nov; 30(4):957-64. PubMed ID: 15666853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anorectal and urinary anomalies and aberrant retinoic acid metabolism in cytochrome P450 oxidoreductase deficiency.
    Fukami M; Nagai T; Mochizuki H; Muroya K; Yamada G; Takitani K; Ogata T
    Mol Genet Metab; 2010 Jul; 100(3):269-73. PubMed ID: 20409737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations.
    Papadakis GE; Dumont A; Bouligand J; Chasseloup F; Raggi A; Catteau-Jonard S; Boute-Benejean O; Pitteloud N; Young J; Dewailly D
    Hum Reprod; 2020 Apr; 35(4):939-949. PubMed ID: 32242900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Idkowiak J; O'Riordan S; Reisch N; Malunowicz EM; Collins F; Kerstens MN; Köhler B; Graul-Neumann LM; Szarras-Czapnik M; Dattani M; Silink M; Shackleton CH; Maiter D; Krone N; Arlt W
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E453-62. PubMed ID: 21190981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency.
    Reisch N; Idkowiak J; Hughes BA; Ivison HE; Abdul-Rahman OA; Hendon LG; Olney AH; Nielsen S; Harrison R; Blair EM; Dhir V; Krone N; Shackleton CH; Arlt W
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E528-36. PubMed ID: 23365120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype.
    Shackleton C; Marcos J; Arlt W; Hauffa BP
    Am J Med Genet A; 2004 Aug; 129A(2):105-12. PubMed ID: 15316970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.
    Sahakitrungruang T; Huang N; Tee MK; Agrawal V; Russell WE; Crock P; Murphy N; Migeon CJ; Miller WL
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4992-5000. PubMed ID: 19837910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
    Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambiguous genitalia, impaired steroidogenesis, and Antley-Bixler syndrome in a patient with P450 oxidoreductase deficiency.
    But WM; Lo IF; Shek CC; Tse WY; Lam ST
    Hong Kong Med J; 2010 Feb; 16(1):59-62. PubMed ID: 20124576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Zhang J; Woo KL; Hai Y; Wang S; Lin Y; Huang Y; Peng X; Wu H; Zhang S; Yan L; Li Y
    Front Endocrinol (Lausanne); 2022; 13():1020880. PubMed ID: 36518257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of a female with congenital adrenal hyperplasia due to P450-oxidoreductase deficiency.
    Bonamichi BD; Santiago SL; Bertola DR; Kim CA; Alonso N; Mendonca BB; Bachega TA; Gomes LG
    Arch Endocrinol Metab; 2016 Oct; 60(5):500-504. PubMed ID: 27737328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency.
    Scott RR; Gomes LG; Huang N; Van Vliet G; Miller WL
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2318-22. PubMed ID: 17389698
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.